This study was designed to better characterise in humans the mechanism of action of rilmenidine, a new antihypertensive oxazoline derivative. The functional relationship between hypotensive response, adrenergic nerve activity and platelet α2-adrenoceptor number and function was evaluated in hypertensive subjects, both before and after prolonged treatment with this drug. The effect of rilmenidine were compared with those induced by a diuretic drug (hydrochlorothiazide). After 1 month of placebo, 24 patients with essential hypertension were randomly allocated to either rilmenidine 1 mg once daily or hydrochlorothiazide 25 mg once daily. At the end of the first month of treatment, the 2 drugs were combined in the patients whose diastolic blood pressure was higher than 90 mmHg. On days, 0, 30, and 60, the number and affinity of blood platelet α2-adrenoceptors were measured by 3H-yohimbine labelling, and plasma catecholamines were determined. On days 0 and 30, platelet aggregation was also ossessed. The results show that the administration of rilmenidine exerts significant and lasting antihypertensive activity. This effect, however, is not associated with a modification in platelet α2-adrenoceptor density and function, nor does it seem to affect catecholamine plasma levels, thus suggesting a negligible role for α2-adrenoceptor stimulation in the antihypertensive action of rilmenidine.

Effects of rilmenidine and hydrochlorothiazide on human platelet α2-adrenoceptors

FISCHETTI, Fabio;CARRETTA, RENZO;FABRIS, BRUNO;BARDELLI, MORENO;
1993-01-01

Abstract

This study was designed to better characterise in humans the mechanism of action of rilmenidine, a new antihypertensive oxazoline derivative. The functional relationship between hypotensive response, adrenergic nerve activity and platelet α2-adrenoceptor number and function was evaluated in hypertensive subjects, both before and after prolonged treatment with this drug. The effect of rilmenidine were compared with those induced by a diuretic drug (hydrochlorothiazide). After 1 month of placebo, 24 patients with essential hypertension were randomly allocated to either rilmenidine 1 mg once daily or hydrochlorothiazide 25 mg once daily. At the end of the first month of treatment, the 2 drugs were combined in the patients whose diastolic blood pressure was higher than 90 mmHg. On days, 0, 30, and 60, the number and affinity of blood platelet α2-adrenoceptors were measured by 3H-yohimbine labelling, and plasma catecholamines were determined. On days 0 and 30, platelet aggregation was also ossessed. The results show that the administration of rilmenidine exerts significant and lasting antihypertensive activity. This effect, however, is not associated with a modification in platelet α2-adrenoceptor density and function, nor does it seem to affect catecholamine plasma levels, thus suggesting a negligible role for α2-adrenoceptor stimulation in the antihypertensive action of rilmenidine.
1993
http://www.scopus.com/inward/record.url?eid=2-s2.0-0027493462&partnerID=40&md5=1f9b52e8b033f6008cc806bb174a520d
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11368/2635098
 Avviso

Registrazione in corso di verifica.
La registrazione di questo prodotto non è ancora stata validata in ArTS.

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact